Log in to save to my catalogue

Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept thera...

Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept thera...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1904210451

Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy

About this item

Full title

Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy

Publisher

Washington: American Association for the Advancement of Science

Journal title

Science (American Association for the Advancement of Science), 2015-07, Vol.349 (6246), p.436-440

Language

English

Formats

Publication information

Publisher

Washington: American Association for the Advancement of Science

More information

Scope and Contents

Contents

Mutations in the LRBA gene (encoding the lipopolysaccharide-responsive and beige-like anchor protein) cause a syndrome of autoimmunity, lymphoproliferation, and humoral immune deficiency. The biological role of LRBA in immunologic disease is unknown. We found that patients with LRBA deficiency manifested a dramatic and sustained improvement in resp...

Alternative Titles

Full title

Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1904210451

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1904210451

Other Identifiers

ISSN

0036-8075

E-ISSN

1095-9203

DOI

10.1126/science.aaa1663

How to access this item